home / stock / swkh / swkh news


SWKH News and Press, SWK Holdings Corporation From 09/01/22

Stock Information

Company Name: SWK Holdings Corporation
Stock Symbol: SWKH
Market: OTC
Website: swkhold.com

Menu

SWKH SWKH Quote SWKH Short SWKH News SWKH Articles SWKH Message Board
Get SWKH Alerts

News, Short Squeeze, Breakout and More Instantly...

SWKH - SWK Holdings Announces Leadership Transition

SWK Holdings Announces Leadership Transition PR Newswire Jody Staggs appointed as President and Interim CEO CEO Winston Black will assist in an interim consulting role after successfully establishing SWK Holdings as a leading life science focused specia...

SWKH - SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2022 Results - Earnings Call Transcript

SWK Holdings Corporation (SWKH) Q2 2022 Earnings Conference Call August 11, 2022 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors Winston Black - Chairman and CEO Conference Call Participants Kyle Bauser - Lake Street Capital Mar...

SWKH - SWK Holdings GAAP EPS of $0.04 misses by $0.16, revenue of $6.94M misses by $1.76M

SWK Holdings press release ( NASDAQ: SWKH ): Q2 GAAP EPS of $0.04 misses by $0.16 . Revenue of $6.94M (-68.9% Y/Y) misses by $1.76M . For further details see: SWK Holdings GAAP EPS of $0.04 misses by $0.16, revenue of $6.94M misses by $1.76M

SWKH - SWK Holdings Corporation Announces Financial Results for Second Quarter 2022

SWK Holdings Corporation Announces Financial Results for Second Quarter 2022 PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET Corporate Highlights Celebrated 10 th anniversary as a...

SWKH - SWK Holdings Corporation to Report Second Quarter 2022 Financial Results

SWK Holdings Corporation to Report Second Quarter 2022 Financial Results PR Newswire Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022 , at 10:00 a.m. ET DALLAS , Aug. 9, 2022 /PRNewswire/ -- SWK Holdings...

SWKH - Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing

Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsour...

SWKH - Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo

Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo PR Newswire BOONTON, N.J. ...

SWKH - SWK Holdings Corporation Marks 10th Anniversary, Celebrating Growth and Progress

SWK Holdings Corporation Marks 10th Anniversary, Celebrating Growth and Progress PR Newswire Since 2012, SWK Holdings has completed financings with 46 life sciences companies, deploying $650 million of capital Second Quarter 2022 Financial Results to be Ann...

SWKH - SWK Holdings added to Russell 3000, Russell 2000 and Russell microcap Indexes

SWK Holdings (NASDAQ:SWKH) added to the Russell 2000, Russell 3000 and Russell MicroCap Indexes as part of their annual reconstitution, effective after the U.S. market opens on Monday, June 27, 2022. "SWK's return to these indexes is an affirmation of the value that we are building for t...

SWKH - Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference

Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference PR Newswire Data suggest that oral formulations of leuprolide developed utilizing Enteris' Peptelligence ® platform successfully ...

Previous 10 Next 10